Coherus Seeks IPO Raising $108.6M To Fund New Drugs
Coherus BioSciences Inc., a California biotech developing drugs patterned after existing blockbusters about to come off patent, will seek up to $108.6 million in an initial public offering designed to speed...To view the full article, register now.
Already a subscriber? Click here to view full article